Search for: "Teva Branded Pharmaceutical Products R"
Results 41 - 60
of 96
Sorted by Relevance
|
Sort by Date
19 Mar 2015, 12:41 pm
Some generic drug makers and insurers want biosimilars to have the same generic name as the branded product, because that would make it easier for doctors to use them as substitutes. [read post]
15 Apr 2010, 7:04 am
By Kurt R. [read post]
6 Jan 2010, 3:32 am
’ (The SPC Blog) India: Reviewing the Indian Patent Regime after 5 years of the introduction of the pharmaceutical product patent regime (Spicy IP) UK: Department of Health proposing generic prescription drugs option (GenericsWeb) US: 7th Circuit: Enforcing contracts between joint owners: Wisconsin Alumni Research Foundation (WARF) v. [read post]
28 Dec 2010, 10:58 am
By Kurt R. [read post]
30 Oct 2014, 12:02 pm
They simply seek information about operation and production costs. [read post]
10 Oct 2008, 11:32 am
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) - US: Trial judge grants permanent injunction in case relating to recombinant erythropoietin (EPO) patent: Amgen v… [read post]
17 Jan 2008, 10:00 pm
,Local ‘Fair copyright for Canada Facebook' groups take off: (Michael Geist),Federal Court of Appeal quashes Copyright Board's proposed iPod levy: (Ars Technica),DMCA used to sue over bad movie review: (Michael Geist),A new copyright pledge for MPs: (Michael Geist),Press coverage of copyright debate: (Michael Geist), (Michael Geist), (Michael Geist),Michael Geist's fair copyright for… [read post]
5 Dec 2008, 1:00 pm
You can separately subscribe to the Pharma & Biotech Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360)… [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
25 Jan 2011, 10:58 pm
Highlights this week included: WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid:… [read post]
14 Dec 2010, 6:12 pm
One products liability lawsuit was originally filed by Gladys Mensing, who is suing Teva Pharmaceutical Industries Ltd., Mylan Inc., and Actavis Group. [read post]
1 Jul 2009, 7:14 am
(The SPC Blog) EU: Germany refers question to ECJ concerning SPCs for plant protection products (The SPC Blog) EU: Nutritional supplements: is Class 5 their natural home? [read post]
1 Dec 2007, 9:00 am
pharmaceutical companies: (SpicyIP),Great discussion on pharmaceuticals, patents and incentives for innovation: (Generic Pharmaceuticals & IP), (DrugWonks),Adenoscan (Adenosine) - Astellas Pharma, King Pharmaceuticals, and Teva Settle Adenoscan ® Patent Suit: (PatentDocs), Clarinex (Desloratadine) - Schering Corp. adds Anchen Pharmaceuticals Inc. to the long list of companies sued for patent infringement: (IPLaw360), Cosopt… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
10 Jun 2013, 8:20 pm
The one-pill version is made by Teva Pharmaceutical Products. [read post]
16 Nov 2009, 4:51 am
(Marques) Russia Carrefour, brands and the Russian market (IP finance) South Africa Supreme Court of Appeal decision in Mr Video case concerning parallel importation of DVDs (Afro-IP) Sweden Can Sweden bring political IP unity before year's end? [read post]
16 Nov 2009, 4:51 am
(Marques) Russia Carrefour, brands and the Russian market (IP finance) South Africa Supreme Court of Appeal decision in Mr Video case concerning parallel importation of DVDs (Afro-IP) Sweden Can Sweden bring political IP unity before year’s end? [read post]
16 Nov 2009, 4:51 am
(Marques) Russia Carrefour, brands and the Russian market (IP finance) South Africa Supreme Court of Appeal decision in Mr Video case concerning parallel importation of DVDs (Afro-IP) Sweden Can Sweden bring political IP unity before year's end? [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
